https://doi.org/10.4081/monaldi.2024.2865
Evaluation of patients’ satisfaction with domiciliary biological treatment in severe asthma: a Portuguese survey
Submitted: December 4, 2023
Accepted: March 14, 2024
Published: March 20, 2024
Accepted: March 14, 2024
Abstract Views: 354
PDF_EARLY VIEW: 149
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Dear Editor,
According to GINA, severe asthma is defined as uncontrolled asthma, despite therapy adherence with an optimized high dose of inhaled corticosteroid plus long-acting ß2-agonist coupled with management of modifiable factors/comorbidities, that worsens when this treatment is decreased. It affects a significant portion of asthmatic patients and imposes a high risk of exacerbations and mortality, which are associated with significant healthcare costs and psychosocial impact...
GINA. 2023 GINA report, global strategy for asthma management and prevention. 2023. Available from: https://ginasthma.org/2023-gina-main-report/.
Lombardi C, Bagnasco D, Passalacqua G. Biological agents for severe asthma: the evolution of the at-home self-injection approach. Curr Opin Allergy Clin Immunol 2020;20:421-7.
DOI: https://doi.org/10.1097/ACI.0000000000000656
Sitek A, Li JT, Pongdee T. Risks and safety of biologics: a practical guide for allergists. World Allergy Organ J 2023;16:100737.
DOI: https://doi.org/10.1016/j.waojou.2022.100737
Blok F, Kocks J, Wouters H, et al. Perceptions on home-administration of biologics in the context of severe asthma: an international qualitative study. J Aller Cl Imm-Pract 2022;10:2312-23.e2.
DOI: https://doi.org/10.1016/j.jaip.2022.04.015
Ethics Approval
The study protocol was approved by the Ethics Committee for Health of ULS Matosinhos (institutional committee of the Pedro Hispano Hospital), document no 86/CES/JAS.How to Cite
Lourenço, Joana, Ana Paula Vaz, Rosa Anita Fernandes, Cristina Lopes, and Ana Luísa Fernandes. 2024. “Evaluation of patients’ Satisfaction With Domiciliary Biological Treatment in Severe Asthma: A Portuguese Survey”. Monaldi Archives for Chest Disease, March. https://doi.org/10.4081/monaldi.2024.2865.
Copyright (c) 2024 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- R.W. Dal Negro, R. Aquilani, S. Bertacco, F. Boschi, C. Micheletto, S. Tognella, Comprehensive effects of supplemented essential amino acids in patients with severe COPD and sarcopenia , Monaldi Archives for Chest Disease: Vol. 73 No. 1 (2010): Pulmonary series
- Francesco Barillà , Concetta Torromeo, Riccardo Iorio, Luigina Porco, Vincenzo Paravati, Carlo Gaudio, Antiplatelet therapy in elderly patients with acute coronary syndrome: Between scientific evidence and future perspectives , Monaldi Archives for Chest Disease: Vol. 88 No. 2 (2018)
- Francesco Fattirolli, Elisabetta Angelino, The bare minimum of information at discharge after acute coronary syndrome. Part 2: the quality improvement project , Monaldi Archives for Chest Disease: Vol. 78 No. 3 (2012): Cardiac series
- L.R. Codecasa, M. Ferrarese, V. Penati, C. Lacchini, D. Cirillo, C. Scarparo, P. Piccoli, C. Piersimoni, G.B. Migliori, Comparison of Tuberculin Skin test and Quantiferon immunological assay for latent Tuberculosis infection , Monaldi Archives for Chest Disease: Vol. 63 No. 3 (2005): Pulmonary series
- Mariana Buziashvili, Hayk Davtyan, Yuliia Sereda, Olga Denisiuk, Ogtay Gozalov, Nino Lomtadze, Arax Hovhannesyan, Incidence rate and time to serious adverse events among rifampicin resistant tuberculosis patients in Georgia treated with new and repurposed anti-tuberculosis drugs, 2016-2018 , Monaldi Archives for Chest Disease: Vol. 91 No. 1 (2021)
- B.D. Grigoriu, C. Grigoriu, B. Chahine, T. Gey, A. Scherpereel, Clinical utility of diagnostic markers for malignant pleural mesothelioma , Monaldi Archives for Chest Disease: Vol. 71 No. 1 (2009): Pulmonary series
- Nesrine Lamine, Apostolos C. Agrafiotis, Ines Lardinois, Lipiodol lymphangiography as a treatment for refractory postoperative chylothorax: a case report , Monaldi Archives for Chest Disease: Vol. 91 No. 4 (2021)
- M. Confalonieri, M. Kodric, M. Santagiuliana, C. Longo, M. Biolo, R. Cifaldi, C. Torregiani, M. Jevnikar, To use or not to use corticosteroids for pneumonia? A clinician’s perspective , Monaldi Archives for Chest Disease: Vol. 77 No. 2 (2012): Pulmonary series
- Christopher Ull, Mirko Aach, Josef Reichert, Thomas Armin Schildhauer, Justyna Swol, Successful non-surgical management of pleuroparenchymal fistula following cervical intraspinal empyema , Monaldi Archives for Chest Disease: Vol. 88 No. 1 (2018)
- P.E. Van Schil, J.M. Hendriks, M.G. De Maeseneer, P.R. Lauwers, Current management of spontaneous pneumothorax , Monaldi Archives for Chest Disease: Vol. 63 No. 4 (2005): Pulmonary series
<< < 9 10 11 12 13 14 15 16 17 18 > >>
You may also start an advanced similarity search for this article.
